Upstate Active Clinical Trials

Study Title:

CALGB 51101-A Randomized Phase II Trial of Myeloablative Versus Non-Myeloablative Consolidation Chemotherapy for Newly Diagnosed Primary CNS B-cell Lymphoma

What is the purpose of the study?

This randomized phase II trial studies how well combination chemotherapy given together with autologous stem cell transplant works compared to combination chemotherapy alone in treating patients with central nervous system B-cell lymphoma.

Upstate Institutional Review Board (IRB) Number:

353928

Study Phase:

II

Patient Age Group:

Adults

Principal Investigator:

Thomas E Coyle, MD

ClinicalTrials.Gov ID:

NCT01511562

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Joanne M Chilton, CCRP
Phone: 315-464-8240
Email: chiltonj@upstate.edu

Return to Previous Page || Search Again